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Abstract
Objectives To assess the performance of the BComputer-
Aided Nodule Assessment and Risk Yield^ (CANARY) soft-
ware in the differentiation and risk assessment of histological
subtypes of lung adenocarcinomas manifesting as pure ground
glass nodules on computed tomography (CT).
Methods 64 surgically resected and histologically proven ade-
nocarcinomas manifesting as pure ground-glass nodules on CT
were assessed using CANARY software, which classifies
voxel-densities into three risk components (low, intermediate,
and high risk). Differences in risk components between histo-
logical adenocarcinoma subtypes were analysed. To determine
the optimal threshold reflecting the presence of an invasive
focus, sensitivity, specificity, negative predictive value, and
positive predictive value were calculated.
Results 28/64 (44%) were adenocarcinomas in situ (AIS); 26/
64 (41%) were minimally invasive adenocarcinomas (MIA);
and 10/64 (16%) were invasive ACs (IAC). The software
showed significant differences in risk components between
histological subtypes (P<0.001–0.003). A relative volume of
45% or less of low-risk components was associated with his-
tological invasiveness (specificity 100%, positive predictive
value 100%).
Conclusions CANARY-based risk assessment of ACs mani-
festing as pure ground glass nodules on CT allows the differ-
entiation of their histological subtypes. A threshold of 45% of
low-risk components reflects invasiveness in these groups.
Key points
• CANARY-based risk assessment allows the differentiation of
their histological subtypes.
• 45% or less of low-risk component reflects histological
invasiveness.
• CANARY has potential role in suspected adenocarcinomas
manifesting as pure ground-glass nodules.
Keywords Lung adenocarcinoma . Pure ground glass
nodule .Riskstratification .Computed tomography .Software
based
Introduction
The BComputer Aided Nodule Assessment and Risk Yield^
(CANARY) software package has recently been introduced
for risk stratification of pulmonary nodules of the
lung adenocarcinoma spectrum [1]. CANARY is based on
assessing voxel densities of pulmonary nodules and the sub-
sequent assignment of risk, as inferred from histology, accord-
ing to voxel proportion and clustering.While this software has
been successful in assessing both histology and outcome in a
representative but morphologically diverse number of lung
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adenocarcinomas (AC) [1–3], it has not yet been tested in lung
adenocarcinomas with morphologically more uniform appear-
ance on computed tomography (CT).
A distinct subgroup of lung adenocarcinomas with a more
uniform CT appearance, are those manifesting as pure ground
glass nodules. They are considered to reflect a specific sub-
group of adenocarcinomas with tailored management recom-
mendations according to the ‘Guidelines for Management of
Incidental Pulmonary Nodules Detected on CT Images: From
the Fleischner Society 2017 [4]. These adenocarcinomas man-
ifesting as pure ground glass nodules are important because
they are common and can represent different histologic sub-
types, ranging from noninvasive adenocarcinoma in situ (AIS)
to invasive subtypes such as minimally invasive ACs (MIAs)
and invasive ACs (IACs) [5]. A tool to differentiate among
these histological subtypes in lung ACs could help to reduce
diagnostic uncertainty in the management of such nodules.
Therefore, the specific purpose of our study was to investigate
the performance of CANARY software in the differentiation
and risk assessment of histological subtypes of lung adenocar-
cinomas manifesting as pure ground glass nodules on CT.
Materials and methods
The protocol for this retrospective study (#15-020) was ap-
proved by our institutional review board with the need for
written informed consent waived.
Study population
This retrospective study was based on a radiology-pathology
data repository, which has served for other studies in the past,
with a partial overlap of lesions and patients [6–8]. We
reviewed the medical records of patients undergoing surgical
resection for primary pulmonary adenocarcinoma (AC) at our
institution between January 2005 and July 2016. Inclusion
criteria were: (1) histologically verified primary pulmonary
AC; (2) available pre-operative computed tomography (CT)
examination; and (3) AC manifesting as pure ground glass
nodule (GGN) on CT. Exclusion criteria were (1) histologic
diagnosis other than AC; (2) pre-operative CT examination
not available; (3) AC manifesting as a solid or part-solid
nodule on CT; and (4) pathologically described nodule not
identifiable on CT.
The medical record review resulted in 698 resected ACs,
of which 89 (12.4%) were excluded because pre-operative
CT examinations were not available. After further radiologic
consensus review by two thoracic radiologists (AAB and
BHH, with 20 and 2 years of experience, respectively),
546/611 (89.4%) adenocarcinomas were excluded because
either the nodules were not identifiable on CT or they man-
ifested as solid or part-solid lesions. Thereafter, the surgical
resected specimens of the 65 remaining ACs were re-
reviewed by a subspecialty-trained thoracic pathologist
(PAV) and a senior pathology resident (KRA). This histo-
pathological consensus review excluded 1/65 (1.5%) nodule
because it was an atypical adenomatous hyperplasia (AAH).
This left 64 adenocarcinomas manifesting as pure GGNs for
CANARY analysis.
CTacquisitions
CT examinations were performed using various CT scanner
units and acquisition protocols, which were all considered
state-of-the-art at the time of acquisition. The most frequently
used CT units were Aquilion One (Toshiba, 320-detector
row), Discovery CT750 HD (GE Medical Systems, 64-
detector row), and Lightspeed VCT (GE Medical Systems,
64-detector row).
All CT examinations were performed in the supine body
position, at full inspiration, covering the entire lung.
Examinations before April 2007 were performed with fixed
mAs (range: 130-340 mAs) and 120 kVp. After April 2007,
automated exposure control and other dose reduction algo-
rithms were used. Transverse images were reconstructed with
0.625 to 1.5 mm section thickness using standard reconstruc-
tion kernels in lung window settings (mean, −500 HU; width,
1500HU). CTexaminations for staging purposes (n=21, 36%)
were performed using intravenous contrast material. In the
remaining 38 (64%) examinations, no contrast material was
administered.
CT
The CT examinations were anonimised and presented in a
random order on a picture archiving and communication sys-
tem (GE Healthcare, Centricity) to two thoracic radiologists
independently. Both radiologists were unaware of clinical
and histological information. The long-axis and short-axis
diameters of all 64 ACs were measured. Measurements were
performed in lung window setting on the transverse CT sec-
tion that displayed the largest nodule dimensions.
Measurements were recorded in millimetres. Average CT
diameters were calculated based on the long- and short-axis
diameter.
Computer Aided Nodule Assessment and Risk Yield
(CANARY)
All included nodules were also analysed by CANARY, a soft-
ware for automated risk assessment of ACs based on the re-
duction of voxel density histograms to nine natural clusters. In
a pilot study, these clusters were identified by selecting 774
regions of interest (two dimensional area ROIs, 9 x 9 voxels)
in 37 ACs and comparing all ROIs to one another using
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Affinity Propagation and pairwise similarity metrics [1].
Exemplars were generated from these nine natural clusters
and color-coded as violet (V), indigo (I), blue (B), green
(G), yellow (Y), orange (O), red (R), cyan (C) and pink (P).
These exemplars were then used for allocation of nodule risk
components. To allocate nodule risk components, the 9 x 9
region around each voxel within the segmented nodule is
compared to these nine exemplars to determine which cluster
the voxel is most similar to. This results in a specific combi-
nation of colour codes for each nodule. A representative nod-
ule is shown in Fig. 1.
For lung nodule characterisation, all 64 GGNs were located
by one observer (UN, 4 years of experience in general radiol-
ogy) using OsiriX (v8.0.1, Pixmeo SARL, Bernex,
Switzerland). Initial data processing steps involved the seg-
mentation of the nodule with the brush tool and pre-
determined pixel values for inside and outside the ROIs.
Predetermined pixel-values were arbitrarily defined numbers
required by the CANARY algorithm to determine what is
inside or outside of the ROI. ROIs were then saved as
DICOMs and uploaded for CANARY analysis. Time needed
for CANARYanalysis averaged 10 minutes per lesion.
For each nodule, the CANARY analysis yielded the abso-
lute and relative volume of each colour. These nine colours
were then combined into three components as determined by
Maldonado et al. [1]: (1) low risk – blue-green-cyan; (2) in-
termediate risk – pink-yellow; and (3) high risk – violet-indi-
go-red-orange.
The absolute and relative volumes of the three components
of each nodule were then used for analysis.
Histologic Review
The original histologic glass slides from all 64 resected nod-
ules were retrieved and re-reviewed by a subspecialty-
trained thoracic pathologist (PAV, 5 years of experience)
and a senior pathology chief resident (KRA, PGY4). The
histologic growth patterns (including the non-invasive/in-
ferred in-situ lepidic pattern as well as any invasive patterns
including acinar, papillary, micropapillary, and solid growth)
were recorded in semiquantitative 5% increments according
to current practice recommendations [9]. The size and num-
ber of any invasive foci (by definition, any histologic pattern
other than lepidic) were assessed. Based on this information,
these adenocarcinomas were classified using current WHO
terminology and diagnostic criteria as AIS, MIA, or IAC
[9]. AIS is defined as a solitary lung adenocarcinoma
≤3.0 cm demonstrating a pure lepidic growth pattern with-
out evidence of stromal, vascular, or pleural invasion, tu-
mour necrosis, or spread of tumour through the airspaces.
MIA is defined as a solitary lung adenocarcinoma ≤3.0 cmwith
a predominantly lepidic growth pattern but that contains an
invasive focus (i.e., growth pattern other than lepidic) that is
≤0.5 cm in greatest dimension, and also lacks lymphatic, vas-
cular, or pleural invasion, tumour necrosis, or spread of tumour
through the airspaces. In contrast, IAC are lung adenocarci-
nomas that either are greater than 3.0 cm, have an invasive
growth pattern greater than 0.5 cm, or that demonstrate any of
the more aggressive features lacking in AIS orMIA (lymphat-
ic, vascular, or pleural invasion, tumour necrosis, or spread of
tumour through the airspaces). Any discrepancies in tumour
component measurement or classification between PAV and
KRA were resolved via multihead microscope consensus
review.
Statistical analysis
All statistical analyses and graphs were performed using com-
mercially available software (STATA 12.0, StatCorp, College
Station, TX, USA). The normality of distributions was
assessed by the Shapiro-Wilk test. Normally distributed data
were expressed as mean ± SD. Non-normally distributed data
were expressed as median together with their [interquartile
range]. Statistical Power Analysis was performed using
STATA module for simulation-based power analysis. A p val-
ue less than 0.05 was considered statistically significant.
First, we calculated the distribution of AIS,MIA, and IACs
of the 64 GGNs included in this study.
Second, we calculated the medians of the low risk, inter-
mediate risk, and high risk CANARY components for AIS,
MIA, and IACs, respectively. Potential differences between
the CANARY components in the histological subtypes, name-
ly AIS, MIAs and IACs, were assessed for statistical signifi-
cance using a Kruskal-Wallis test, with individual differences
additionally assessed with Conover-Iman tests.
Third, we tested the strength of the relation of the size of
invasive foci with both volume and percentage of the three
CANARY components by calculating Spearman-rank corre-
lation coefficients. All P-values obtained from Spearman cor-
relation were Bonferroni corrected.
Fourth, to assess the presence of invasive foci, we grouped
the two histological components with an invasive component,
namelyMIAs and IACs, and plotted individual percentages of
the low risk and intermediate risk group, respectively.
Based on those individual percentages, we defined thresh-
old values for low risk group in intervals of five percentages
starting at 40%. To determine the optimal threshold reflecting
the presence of an invasive focus, we calculated sensitivity,
specificity, negative predictive value (NPV), and positive pre-
dictive value (PPV) for each threshold value.
To assess the influence of contrast material administration
on the CANARY analysis, we performed a linear regression
analysis with CANARY components as dependent variables
and contrast administration and section thickness as indepen-
dent variables.
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Results
The 64 ACs manifesting as pure GGNs on CT were detected
in 59 patients, 5/59 (8%) of whom had more than one
resected GGN, but no patient had more than two resected
nodules.
There were 40/59 (67.8%) women (mean age 67±9 years;
range, 45-84 years), and 19/59 (32.2%) men (mean age 69±9
years; range, 49-86 years). There was no significant difference
in age between women and men (P=0.439). The median du-
ration between the CT examination and surgical resection was
1 month [IQR 0-2].
GGNs were located as follows: right upper lobe (22; 34%);
left upper lobe (18; 28%); right lower lobe (13; 20%), left
lower lobe (9; 14%) and the right middle lobe (2; 3%).
Twenty-five (39%) of the nodules were removed by lobec-
tomy, 28 (44%) by wedge resection, and 11 (17%) by
segmentectomy.
Using an alpha level of 0.05, retrospective power analysis
showed a statistical power of 0.95 for low risk components,
0.94 for intermediate risk component and 0.55 for high risk
component.
Of the 64 GGNs included in our study, 28 (44%) were AIS,
26 (41%) were MIAs, and 10 (16%) were IACs. The average
CT diameter of the nodules was 14.4± 5.3 mm.
Examples of CANARYassessment for AIS, MIA, and IAC
are displayed in Figs. 2, 3 and 4. The three CANARY com-
ponents for AIS, MIA, and IACs are displayed in Table 1. The
volumes of the low risk CANARY component did not differ
significantly between AIS, MIAs, and IACs (P=0.408). The
volumes of the intermediate risk group were significantly low-
er in AIS than in MIAs (P=0.003), and lower in AIS than in
IACs (P<0.001). However, the volume difference between
MIAs and IACs was not statistically significant (P=0.055).
The volumes of the high risk group were significantly lower
in AIS than in MIAs (P=0.040), in AIS than in IACs
(P<0.001), and in MIAs than IACs (P=0.001).
The percentages of the low risk CANARY component
were significantly higher in AIS than MIAs (P=0.034), in
AIS than IACs (P<0.001), and in MIAs than IACs
(P=0.024). The percentages of the intermediate risk compo-
nent were significantly lower in AIS than MIAs (P=0.037), in
AIS than IACs (P<0.001), and in MIAs than IACs (P=0.016).
The percentages of the high risk group were significantly low-
er in AIS than in MIAs (P=0.037), in AIS than in IACs
(P<0.001), and in MIAs than IACs (P=0.002).
The relations of the size of the invasive focus and the
volumes of the intermediate and high risk components were
statistically significant (r=0.477, P<0.001, and r=0.471,
P<0.001, respectively). However, the relation of the size of
Fig. 2 (a) Color-coded CANARY output overlay of adenocarcinoma in
situ (blue-green-cyan-pink) (low risk 94.9%, intermediate risk 5.1%, high
risk 0%);. (b) histologic image showing patchy interstitial chronic
inflammation, but a purely lepidic tumour grown pattern without areas
of invasion (H&E stain, 100x original magnification)
Fig. 1 (a) Transverse computed
tomography image of an
adenocarcinoma in situ
manifesting as pure ground glass
nodule in the left upper lobe (b)
Color-coded CANARYoutput
overlay shows components of low
risk group (blue-green–cyan)
(low risk 99.8%, intermediate risk
0.2%, high risk 0%) (c) histologic
image showing purely lepidic
tumour growth pattern without
areas of invasion (H&E stain,
200x original magnification)
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the invasive focus and the volume of the low risk compo-
nent was not statistically significant (r=0.200, P=0.679). The
relations between the percentage of the three CANARY
components with the size of invasive focus were statistically
significant (low risk: r=-0.406, P=0.005; intermediate risk:
r=0.407, P=0.005; high risk: r=0.467, P<0.001),
respectively.
Individual percentages of the low risk group are
displayed in Fig. 5. For each threshold value, sensitivity,
specificity, NPV, and PPV are shown in Table 2.
Individual percentages of intermediate risk group are
shown in Supplementary Fig. 1.
Linear regression analysis showed no relation between
CANARY component percentages and contrast material ad-
ministration (P=0.331 to 0.664) as well as section thickness
(P=0.255 to 0.762).
Discussion
Our study showed that in ACs manifesting as pure ground
glass nodules on CT, CANARY software allowed the differ-
entiation of the histological subtypes AIS, MIA and IAC. The
analysis software indeed showed statistically significant dif-
ferences in risk components between these three subtypes.
Previously published studies also showed differences in risk
components between histological AC subtypes [1–3].
However, these studies included morphologically heteroge-
neous groups of ACs, whereas our study showed this in a very
homogeneous group of ACs. Therefore, to the best of our
knowledge, our findings are novel in showing these differ-
ences in a homogenous group by exclusively including only
ACs manifesting as pure ground glass nodules. This is impor-
tant because risk assessment of ACs manifesting as pure
Table 1 Volume and percentages of CANARY components for adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and
invasive adenocarcinoma (IAC)
Low risk Intermediate risk High risk
Volume Percentage Volume Percentage Volume Percentage
(mL) (%) (mL) (%) (mL) (%)
AIS, n=28 1.1±1.2 78.5±17.6 0.3±0.5 21.5±17.6 0.0±0.0 0.0±0.0
(0.2,7.1) (45.2,100.0) (0.0,2.7) (0.0,54.8) (0.0,0.0) (0.0,0.1)
MIA, n=26 1.5±1.7 65.3±27.0 0.9±1.6 32.3±23.5 0.1±0.3 2.4±6.6
(0.2,7.1) (15.5,100) (0.0,8.2) (0.0,71.0) (0.0,1.6) (0.0,29.6)
IAC, n=10 2.3±2.8 46.6±22.9 3.9±6.9 49.9±19.8 0.7±1.9 3.4±5.5
(0.3,7.4) (20.1,90.0) (0.1,23.3) (10.0,66.9) (0.0,6.3) (0.0,17.1)
Data are displayed as mean ± standard deviation, together with (range)
Fig. 3 (a) Color-coded CANARYoutput overlay of minimally invasive
adenocarcinoma (blue-green-cyan-pink-yellow) (low risk 55.7%,
intermediate risk 44.3%, high risk 0%) (b) histologic image showing
the transition zone (dotted line) of peripheral non-invasive lepidic
growth pattern (upper right) and the more central invasive acinar pattern
component (lower left)(H&E stain, 200x original magnification)
Fig. 4 (a) Color-coded CANARY output overlay of invasive
adenocarcinoma (yellow-pink-cyan) (low risk 32.0%, intermediate risk
66.9%, high risk 1%)(b) histologic image from the central area of the
tumour shows the invasive acinar growth pattern (c) histologic image
from the tumour periphery showing non-invasive lepidic growth pattern
and adjacent uninvolved lung parenchyma (H&E stain, 200x original
magnification)
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ground glass nodules is essential for choosing a management
approach such as CT follow-up interval, time of biopsy, and
selection of an appropriate surgical method [10–15].
In our study, the percentage of low risk components de-
creased from AIS to MIA and from MIA to IAC. This likely
mirrors the consistency of CANARY assessment with histo-
logical characteristics of AC subtypes. Simultaneously, the
percentage of intermediate risk and high risk components in-
creased from AIS to MIA and from MIA to IAC. Again, this
may mirror the higher number of invasive foci in these histo-
logical subtypes [16, 17]. Note that in our study, AIS did not
show high risk components which should be expected as AIS
is by definition a pre-malignant neoplasm without invasive
foci [16, 17]. Furthermore, the percentage of high risk com-
ponents was, in general, also low inMIA and IAC, which may
be due to our morphologically homogeneous group of ACs
and its similar attenuation profiles [18]. Our study showed that
analysis software was able to detect differences even in this
very homogeneous group.
Our study also showed that a low risk component threshold
of 45% provided a 100% specificity and positive predictive
value for invasiveness of ACsmanifesting as pure ground glass
nodules. At a threshold of 50%, the PPV was still 93% with a
specificity of 96% and only a minimal gain in sensitivity. This
reflects that below a threshold of 50%, there is a close to 100%
likelihood of the nodule being invasive. This further indicates
that the PPV for invasiveness is the strength of this software
when used in ACs manifesting as pure ground glass nodules.
On the other hand, our results showed a low sensitivity of
approximately 30% for histological invasiveness. A previous-
ly published pilot study reported a sensitivity of 95.4 to 98.7%
and a negative predictive value of 87.5 to 96.8% for a different
histological subcategorization of pulmonary adenocarcinomas
[1]. Therefore, and because this study also included both, solid
and part-solid lesions, the diagnostic performance of these two
studies are difficult to compare.
Previous studies reported lesion size to be an important
predictor for invasiveness in ACs manifesting as pure ground
glass nodules [19, 20]. Lee et al. showed that an overall lesion
size of < 10 mm can be used to differentiate between pre-
invasive and invasive lesions [21]. In contrast, Liu et al. report-
ed lesions smaller than 10 mm also to be invasive ACs [10]. In
our study, we focused on component size rather than on overall
lesion size and our results showed a ratherweak but statistically
significant relation between the size of the invasive focus and
the relative percentages of the three CANARY components.
This suggests that size can but must not be considered a rele-
vant factor for predicting invasiveness. Moreover, size thresh-
olds are controversial. Therefore, the analysis software could
better facilitate in the prediction of invasiveness of ACs. This
prediction is important as patients with suspected invasive nod-
ules are more likely to undergo more follow-up examinations,
earlier biopsies, and more radical surgical resections [17, 22].
In particular, the software may be used in high risk patients.
Our study has several limitations. First, our study included
only surgically resected ACs manifesting as pure ground glass
nodules that were surgically resected and histologically prov-
en to be ACs. For this reason, our nodule sample might have
been skewed towards larger, morphologically more conspicu-
ous or aggressively behaving ground glass nodules. However,
this particular study design warranted a pathologically homo-
geneous sample of nodules. Prospective study data will be
required to confirm our current results. Second, CANARY
analysis is a semiautomatic software tool, requiring the man-
ual drawing of regions of interest, a time consuming factor
Fig. 5 Individual percentages of the CANARY low risk components for
non-invasive (adenocarcinoma in situ) and invasive (minimally invasive
adenocarcinoma and invasive adenocarcinoma) groups Note.- AIS-
adenocarcinoma in situ; MIA - minimally invasive adenocarcinoma:
IAC- invasive adenocarcinoma; Sens – Sensitivity; Spec- Specificity;
PPV-positive predictive value; NPV – negative predictive value
240 Eur Radiol (2018) 28:235–242
that may limit its clinical use. Third, our study may be limited
by the variability in CT protocols. However, at the time of the
CTacquisitions, each individual CTscanner was considered to
be state-of-the-art. All image data were reconstructed with
standard reconstruction algorithms, which have been de-
scribed to be similar between different scanners [23].
Furthermore, to exclude the influence of contrast media ad-
ministration and section thickness, we included these vari-
ables in our statistical analyses. Fourth, we did not address
whether the software is able to differentiate between benign
and malign lesions. However, the density reduction algorithm
was developed by using only pulmonary nodules that were
histologically proven adenocarcinomas of the lung.
Although we believe that the differentiation between benign
or malign lesions is important in daily routine, the focus of our
study was to test the ability of CANARY software to differ-
entiate between histological subtypes of adenocarcinomas
manifesting as pure ground glass nodules. Further studies will
have to assess whether CANARY can differentiate between
benign and malignant lesions.
In conclusion, our study showed that CANARY-based risk
stratification of ACs manifesting as pure ground glass nodules
allows the differentiation of AIS, MIA and IACs, the histo-
logical subtypes of these lesions. Moreover, CANARY soft-
ware reflects invasiveness in this group of ACs manifesting as
pure ground glass nodules using a threshold of 45% or lower
of low risk components. While the precise role of CANARY
in the work-up of ACs remains to be determined, our study
suggests a potential role for this software in suspected ACs
manifesting as pure ground glass nodules on CT, notably for
patients with high risk of invasiveness.
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